These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1119 related items for PubMed ID: 18055990
1. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M. Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990 [Abstract] [Full Text] [Related]
2. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233 [Abstract] [Full Text] [Related]
3. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, Abdel-Sattar RM, Ahmady AM, El-Nakeeb A. Transfus Med; 2008 Feb; 18(1):55-61. PubMed ID: 18279193 [Abstract] [Full Text] [Related]
4. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors. Seo DH, Whang DH, Song EY, Kim HS, Park Q. Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731 [Abstract] [Full Text] [Related]
6. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group. Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857 [Abstract] [Full Text] [Related]
7. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience. O'Brien SF, Fearon MA, Yi QL, Fan W, Scalia V, Muntz IR, Vamvakas EC. Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605 [Abstract] [Full Text] [Related]
8. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran. Sofian M, Aghakhani A, Izadi N, Banifazl M, Kalantar E, Eslamifar A, Ramezani A. Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713 [Abstract] [Full Text] [Related]
9. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Katz L, Strong DM, Tegtmeier G, Stramer S. Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367 [Abstract] [Full Text] [Related]
10. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA. Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909 [Abstract] [Full Text] [Related]
11. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ. Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905 [Abstract] [Full Text] [Related]
12. Low rate of occult hepatitis B virus infection among anti-HBc positive blood donors living in a low prevalence region in Brazil. Silva CM, Costi C, Costa C, Michelon C, Oravec R, Ramos AB, Niel C, Rossetti ML. J Infect; 2005 Jul; 51(1):24-9. PubMed ID: 15979486 [Abstract] [Full Text] [Related]
14. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors. Muselmani W, Habbal W, Monem F. Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787 [Abstract] [Full Text] [Related]
15. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China. Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR. Transfus Apher Sci; 2009 Aug; 41(1):3-7. PubMed ID: 19487161 [Abstract] [Full Text] [Related]
16. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101 [Abstract] [Full Text] [Related]
17. Molecular characterization of occult hepatitis B cases in Greek blood donors. Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A. J Med Virol; 2009 May; 81(5):815-25. PubMed ID: 19319945 [Abstract] [Full Text] [Related]
19. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg]. Ren F, Li H, Zhao H. Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):7-9. PubMed ID: 10322742 [Abstract] [Full Text] [Related]